Page results
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
UCLH has declared a climate and health emergency and has published an action plan to reach net zero carbon dioxide emissions.
-
Information about preparing for and undergoing surgery at University College London Hospitals NHS Foundation Trust.
-
Information about our UCLH Charity, charity funds and associated charities.
-
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
-
RNOH are pleased to launch a series of regular Health and Wellbeing Information and Support Sessions to support patients following a cancer diagnosis and also during/after treatment. Theseā¦
-
The Adult Acute speech and language therapist (SLTs) work across a range of acute hospital specialities.
File results
-
FOI/2023/0609 - Companies that currently have contracts at UCLH
-
FOI/2023/0604 - Patient flow system
-
FOI/2023/0603 - Treatment of dermatological conditions
-
FOI/2023/0497 - List of all laboratories within Pathology
-
FOI/2023/0485 - Heart attacks 2019/22
-
FOI/2023/0487 - Maintenance of corporate estate
-
FOI/2023/0488 - Electronic Patient Record (EPR)
-
FOI/2023/0491 - Treatment for oesophageal and gastric cancer
-
FOI/2023/0493 - Treatments for various diseases
-
FOI/2023/0501 - Central Airway Tumour Management/ Endobronchial Valves for treatment of Emphysema